minaprine
Enable an agent to identify minaprine, assess the form and quality of a material containing it, and determine which handling or research actions are supported by evidence.
Bundle → Layer → Finding → Questions Filled
6 bundles · 11 layers · 15 findings · 26 questions
Minaprine identity and forms Establish the parent identity and its relationship to the actual material being assessed.
Parent structure
Anchor recognition to molecular connectivity and verified identifiers.
Reference identity
Use the parent structure and identifiers as the recognition anchor. Reference: [PubChem minaprine](https://pubchem.ncbi.nlm.nih.gov/compound/Minaprine).
- Does the candidate structure match minaprine's substituted pyridazine, phenyl group, and morpholinoethylamino substituent? definition
- Which authoritative record connects the supplied name and identifier to that structure? provenance
Salt and product boundaries
Separate the parent identity from counterions and finished formulations.
Actual material form
Record salt stoichiometry explicitly; the PubChem hydrochloride record describes a two-HCl composition. Reference: [PubChem minaprine hydrochloride](https://pubchem.ncbi.nlm.nih.gov/compound/33254).
- Is the material the parent compound or a verified salt, and what counterion ratio, water content, or solvation is present? measurement
- Does a supplied commercial name identify the substance form or a finished product requiring a separate linked model? boundary
Minaprine quality and quantification Determine how much minaprine a sample contains and whether its identity and quality are sufficiently established.
Identity and impurities
Connect batch acceptance to analytical evidence.
Analytical specificity
Require methods capable of distinguishing minaprine from related compounds and altered material.
- Which structural and separation measurements confirm minaprine identity independently of the container label? measurement
- Which related substances, residual solvents, or degradation products were assessed, and what detection limits apply? measurement
Content and concentration
Make assay and concentration calculations interpretable across material forms.
Parent-equivalent content
State whether reported quantities refer to the weighed material, its salt, or minaprine parent equivalents.
- Is the reported assay a calibrated content measurement or chromatographic area percentage, and on what moisture basis? measurement
- What verified stoichiometry and assay corrections are needed to prepare the requested minaprine molar concentration? action
Minaprine physical state and stability Qualify physical-property and stability evidence by material form and environment.
Phase and solution behavior
Record properties needed to prepare and recognize the tested material.
Form-specific properties
Attach phase, thermal, and dissolution observations to an identified minaprine form.
- Which melting, decomposition, or other thermal observations were measured for this exact minaprine form and by what method? measurement
- At the proposed solvent composition, pH, temperature, and concentration, does the material dissolve completely and remain dissolved? measurement
Storage and preparation history
Assess whether prior conditions compromise the intended use.
Retained material integrity
Base storage and prepared-solution validity on evidence for the relevant form and container conditions.
- What evidence supports the assigned storage conditions and retest period for this solid or minaprine solution? provenance
- Which observed excursion, precipitate, or analytical change requires reanalysis or rejection before use? action
Minaprine biological evidence Represent pharmacological and metabolic observations with their experimental limits.
Activity and mechanism
Distinguish observed effects from proposed molecular explanations.
Qualified pharmacological claims
An experimental report describes serotonergic and dopaminergic effects while leaving their mechanisms unresolved. Reference: [Pharmacologic profile of minaprine](https://pubmed.ncbi.nlm.nih.gov/3489135/).
- For each claimed monoamine oxidase, uptake, receptor, or cholinergic effect, what direct assay and concentration-response evidence exists? provenance
- Does the observation demonstrate direct target activity, a downstream effect, or an organism-level behavioral response? boundary
Exposure and transformation
Separate administered material from measured parent and transformation-product exposure.
Parent versus product exposure
Keep metabolite identity, formation, and activity claims distinct from evidence about minaprine itself.
- Which metabolites are analytically confirmed in the studied species or biological preparation, and which enzyme assignments have direct evidence? provenance
- Were the reported exposure and effects measured for minaprine itself, an identified metabolite, or unresolved total drug-related material? boundary
Minaprine hazards and use status Connect material handling and proposed use to documented hazard and authorization evidence.
Hazard evidence
Identify applicable material hazards and unresolved toxicological signals.
Form-specific safety assessment
Evaluate the actual minaprine form and operation using traceable hazard records rather than inferring safety from historical use.
- Which current safety data sheet and jurisdictional classification apply to this minaprine form, and are any exposure limits established? provenance
- What primary evidence establishes any convulsion-related hazard, and under which exposure conditions was it observed? provenance
- What containment and disposal requirements follow for the proposed weighing, dissolution, or analytical operation? action
Historical and current status
Track medicinal history and present restrictions by territory and intended use.
Authorized-use boundary
Require dated authority records before treating minaprine as authorized, withdrawn, restricted, or available for a particular purpose.
- Which regulator records establish minaprine's historical authorization or withdrawal, including territory, date, and stated reason? provenance
- What current rules govern acquiring, importing, possessing, or using this material for the proposed purpose in the relevant jurisdiction? action
Evidence and external alignment What the world already says about this thing, gathered so the model can be checked against it.
Reported evidence
Findings from the breadth pass, kept separate from the structural claims.
Check these first
Recalled without web access and unsourced; every item is a lead to verify.
- Which of these check these first hold for the sense of minaprine this model covers, and on what evidence? provenance
Identifiers and schemes
Recalled without web access and unsourced; every item is a lead to verify.
- Which of these identifiers and schemes hold for the sense of minaprine this model covers, and on what evidence? provenance
Real-world use
Recalled without web access and unsourced; every item is a lead to verify.
- Which of these real-world use hold for the sense of minaprine this model covers, and on what evidence? provenance
Failure modes and hazards
Recalled without web access and unsourced; every item is a lead to verify.
- Which of these failure modes and hazards hold for the sense of minaprine this model covers, and on what evidence? provenance
Neighbouring kinds and how to tell them apart
Recalled without web access and unsourced; every item is a lead to verify.
- Which of these neighbouring kinds and how to tell them apart hold for the sense of minaprine this model covers, and on what evidence? provenance
Classifiers Filled
- Family
- Thing Registry
- Category
- Physical world and living systems
- Entry kind
- thing
- Plane
- PHY
- Domain
- PHY.MAT
What it is Filled
Minaprine is a synthetic aminopyridazine compound formerly used as an antidepressant whose clinical use was discontinued because of seizure risk.
In scope
- Minaprine molecular identity and reconciliation of chemical identifiers
- Distinction between the parent compound, protonated forms, and specified salts
- Sample composition, purity, impurities, and condition-dependent physical properties
- Minaprine pharmacology and metabolism with explicit experimental context
- Substance hazards, storage requirements, and jurisdiction-specific use restrictions
Out of scope
- Finished medicinal products, their excipients, packaging, and commercial identity
- Patient diagnosis, prescribing, dosing, and treatment selection
- Manufacturing processes and synthesis equipment
- Independent models of metabolites, analogues, and degradation products
- General models of depression, neurotransmission, or laboratory safety
Why it exists Filled
Enable an agent to identify minaprine, assess the form and quality of a material containing it, and determine which handling or research actions are supported by evidence.
Distinguishing features Filled
- Match the parent molecular structure to 4-methyl-N-(2-morpholin-4-ylethyl)-6-phenylpyridazin-3-amine rather than accepting an antidepressant label as identification.
- Check the parent formula C17H22N4O and PubChem CID 4199 against the supplied structural identifier; formula alone cannot exclude structural isomers.
- Distinguish the parent compound from minaprine dihydrochloride by counterion content and stoichiometry before comparing mass concentrations.
- Require analytical separation from related compounds and transformation products; similar pharmacological activity does not establish chemical identity.
- Treat a historical brand name as a link to a product record, requiring confirmation of its active ingredient and salt form.
What robots and AI may and may not do Filled
Must not
- Recommend it for depression or for any particular person.
- Help supply it outside lawful research or pharmaceutical channels.
- Present its discontinued use as current approved practice.
- Minimize the seizure risk that led to its withdrawal.
Only with a human decision
- Any use of a sample in human research.
- Destroying or transferring research stocks.
May
- Identify minaprine by name, identifiers and documented properties, citing sources.
- Report its withdrawal and the reasons from official and historical sources.
- Check a research sample's documentation against its stated identity.
Moral aspects Filled
- People with depression deserve honest information about treatments that were withdrawn.
- Withdrawn medicines can reappear through unregulated sellers.
Who is affected
- People with depression
- Research participants
- Researchers
Owners Filled
Steward
The research institution holding a sample; medicines regulators for its withdrawn status.
Links to other meta-models Filled
parent
- Q11173 - registry parent class
What else AI and robots need to interact with it Filled
Identity and identifiers required Filled
- Vercy registry: vr.tr.minaprine
- Wikidata: Q6863173 (https://www.wikidata.org/wiki/Q6863173)
Direct properties required Filled
- Parent chemical identity: C17H22N4O; CAS 25905-77-5; PubChem CID 4199; InChIKey LDMWSLGGVTVJPG-UHFFFAOYSA-N
- Parent molar mass: Approximately 298.38 g/mol for the neutral parent
- Material form: Parent compound; specified salt with counterion ratio; hydrate or solvate if demonstrated; solution
- Assay and impurity profile: Mass fraction or amount fraction; chromatographic area percentage recorded separately; method and uncertainty
- Physical behavior: Solubility in mg/mL or mol/L with solvent, pH, and temperature; thermal transitions in °C with method and material form
- Experimental pharmacological activity: Endpoint-specific potency or effect with units, assay system, species, exposure duration, and tested form
- Transformation relationships: Parent-to-metabolite or degradation-product relation with supporting identification evidence
- Permitted-use status: Jurisdiction, date, intended use, authority, and documented status or unknown
Recognition required Filled
- Identity rests on the label and analytical certificate, not appearance.
Capabilities and actions required Filled
- Reconcile a supplier label, analytical result, or historical record with the minaprine parent identity.
- Convert a verified salt amount into parent-equivalent amount using stoichiometry, assay, and water or solvent content.
- Assess whether a minaprine batch is suitable for a specified analytical or research purpose.
- Compare pharmacological observations only after aligning tested form, concentration basis, and experimental conditions.
- Determine whether documented storage, handling, and use conditions cover a proposed operation.
- Flag unresolved identity, quality, or regulatory evidence before releasing material for use.
Hazards and failure modes required Filled
- Seizure risk, which led to discontinuation of clinical use.
- Unregulated material may be mislabelled or contaminated.
Standards and interfaces required Filled
- Globally Harmonized System of Classification and Labelling of Chemicals (GHS), United Nations.
Context of use required Filled
- Minaprine is encountered in historical pharmaceutical records and research on compounds formerly used as antidepressants.
- Reference materials and archived samples may support chemical identification, analytical method development and investigation of its pharmacological effects.
Sources Filled
- Wikidata item Q6863173: minaprine - identity and sense of the item
- Wikipedia: Minaprine - general description of the item
Open questions
- Which authoritative records resolve inconsistent parent-versus-hydrochloride naming and identifier assignments in supplier catalogues?
- What experimentally supported solubility, thermal-transition, ionization, and stability values exist for each relevant minaprine form?
- Which proposed pharmacological mechanisms are directly demonstrated at relevant exposures, and how much activity is attributable to metabolites?
- Which primary regulatory documents establish the reported convulsion-related withdrawal history and current status in each relevant territory?
- Which applicable hazard classifications, exposure limits, and validated impurity acceptance criteria exist for minaprine research materials?
Machine files
Provenance
thing registry research (pass 2) · unreviewed
Built from: models/things/publications/thing-q6863173/spec.json